Does ROZANOLIXIZUMAB Cause Off label use? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Off label use have been filed in association with ROZANOLIXIZUMAB (RYSTIGGO). This represents 2.6% of all adverse event reports for ROZANOLIXIZUMAB.
8
Reports of Off label use with ROZANOLIXIZUMAB
2.6%
of all ROZANOLIXIZUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Off label use From ROZANOLIXIZUMAB?
Of the 8 reports, 3 (37.5%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROZANOLIXIZUMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ROZANOLIXIZUMAB Cause?
Myasthenia gravis (158)
Headache (64)
Drug ineffective (54)
Diarrhoea (41)
Asthenia (36)
Fatigue (34)
Dyspnoea (29)
Nausea (25)
Fall (22)
Therapeutic response shortened (22)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ROZANOLIXIZUMAB Alternatives Have Lower Off label use Risk?
ROZANOLIXIZUMAB vs ROZANOLIXIZUMAB-NOLI
ROZANOLIXIZUMAB vs RUBIDIUM RB-82
ROZANOLIXIZUMAB vs RUCAPARIB
ROZANOLIXIZUMAB vs RUCAPARIB CAMSYLATE
ROZANOLIXIZUMAB vs RUFINAMIDE